Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1

被引:86
作者
Stern, N
Markel, G
Arnon, TI
Gruda, R
Wong, H
Gray-Owen, SD
Mandelboim, O [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
[2] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada
关键词
D O I
10.4049/jimmunol.174.11.6692
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The NK killing activity is regulated by activating and inhibitory NK receptors. All of the activating ligands identified so far are either viral or stress-induced proteins. The class I MHC proteins are the ligands for most of the inhibitory NK receptors. However, in the past few years, several receptors have been identified that are able to inhibit NK killing independently of class I NIHC recognition. We have previously demonstrated the existence of a novel inhibitory mechanism of NK cell cytotoxicity mediated by the homophilic carcinoembryonic Ag (CEA)-related cell adhesion molecule 1 (CEACAM1) interactions. In this study, we demonstrate that CEACAM1 also interacts heterophilically with the CEA protein. Importantly, we show that these heterophilic interactions of CEA and CEACAM1 inhibit the killing by NK cells. Because CEA is expressed on a wide range of carcinomas and commonly used as tumor marker, these results represent a novel role for the CEA protein enabling the escape of tumor cells from NK-mediated killing. We further characterize, for the first time, the CEACAM1-CEA interactions. Using functional and binding assays, we demonstrate that the N domains of CEACAM1 and CEA are crucial but not sufficient for both the CEACAM1-CEACAM1 homophilic and CEACAM1-CEA heterophilic interactions. Finally, we suggest that the involvement of additional domains beside the N domain in the heterophilic and homophilic interactions is important for regulating the balance between cis and trans interactions.
引用
收藏
页码:6692 / 6701
页数:10
相关论文
共 31 条
[1]   A PREDICTED 3-DIMENSIONAL STRUCTURE FOR THE CARCINOEMBRYONIC ANTIGEN (CEA) [J].
BATES, PA ;
LUO, JC ;
STERNBERG, MJE .
FEBS LETTERS, 1992, 301 (02) :207-214
[2]  
Beauchemin N, 1999, EXP CELL RES, V252, P243
[3]   Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells [J].
Beauchemin, N ;
Kunath, T ;
Robitaille, J ;
Chow, B ;
Turbide, C ;
Daniels, E ;
Veillette, A .
ONCOGENE, 1997, 14 (07) :783-790
[4]   CARCINOEMBRYONIC ANTIGEN, A HUMAN-TUMOR MARKER, FUNCTIONS AS AN INTERCELLULAR-ADHESION MOLECULE [J].
BENCHIMOL, S ;
FUKS, A ;
JOTHY, S ;
BEAUCHEMIN, N ;
SHIROTA, K ;
STANNERS, CP .
CELL, 1989, 57 (02) :327-334
[5]   Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes [J].
Boulton, IC ;
Gray-Owen, SD .
NATURE IMMUNOLOGY, 2002, 3 (03) :229-236
[6]   Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function [J].
Chen, DH ;
Iijima, H ;
Nagaishi, T ;
Nakajima, A ;
Russell, S ;
Raychowdhury, R ;
Morales, V ;
Rudd, CE ;
Utku, N ;
Blumberg, RS .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3535-3543
[7]  
CHEUNG PH, 1993, J BIOL CHEM, V268, P24303
[8]   HLA-C IS THE INHIBITORY LIGAND THAT DETERMINES DOMINANT RESISTANCE TO LYSIS BY NK1-SPECIFIC AND NK2-SPECIFIC NATURAL-KILLER-CELLS [J].
COLONNA, M ;
BORSELLINO, G ;
FALCO, M ;
FERRARA, GB ;
STROMINGER, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :12000-12004
[9]   HUMAN CARCINOEMBRYONIC ANTIGEN, AN INTERCELLULAR-ADHESION MOLECULE, BLOCKS FUSION AND DIFFERENTIATION OF RAT MYOBLASTS [J].
EIDELMAN, FJ ;
FUKS, A ;
DEMARTE, L ;
TAHERI, M ;
STANNERS, CP .
JOURNAL OF CELL BIOLOGY, 1993, 123 (02) :467-475
[10]   Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function [J].
Gonen-Gross, T ;
Achdout, H ;
Gazit, R ;
Hanna, J ;
Mizrahi, S ;
Markel, G ;
Goldman-Wohl, D ;
Yagel, S ;
Horejsí, V ;
Levy, O ;
Baniyash, M ;
Mandelboim, O .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1343-1351